|
Zurich, June 29, 2007 (pst). The start-up company Redbiotec AG
commercializes the multiprotein expression system "Mulitbac",
which was developed in the ETH research group of Professor Timothy
Richmond by NCCR scientists Dr. Imre Berger and Dr. Dan Fitzgerald.
The patented technology allows the production of large, human protein
complexes, and bears a great potential for targeted drug development.
The company that started its business in 2006 is headed by Dr. Corinne
John as the CEO, and Mr. Christian Schaub as the President of the
Board.
The prize award ceremony took place June 28 in Solothurn. The company
had already won the second prize of the 2006 Venture Business Plan
Competition and the 2007 Swiss Technology Award.
|
